Complications of bone-anchored hearing aids in pediatric patients

Kraai, Tania; Brown, Colin R.; Neeff, Michel; Fisher, Kate

doi:10.1016/j.ijporl.2011.01.018

Cited by 82 publications

(60 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Even though the complication rate could be considerably reduced thanks to an altered implant surface [6] the risk of periimplantary infection with possible subsequent loss of the percutaneous implant remains. this affects especially children and elderly patients with limited bone quality [9,10]. transcutaneous bone conduction hearing systems overcome these problems since the skin over the implant is intact or closed.…”

Section: Discussionmentioning

confidence: 99%

“…this process may be prolonged in the case of poor bone quality, for example in patients treated with radiation or in children. At worst osseointegration might fail resulting in implant loss [9,10]. In children with substantial conductive hearing loss these complications might lead to prolonged non-use of the BAHS resulting in inadequate hearing and therefore might hinder their speech development.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

The bonebridge as a transcutaneous bone conduction hearing system: preliminary surgical and audiological results in children and adolescents

Hassepaß

Bulla

Aschendorff

et al. 2014

Eur Arch Otorhinolaryngol

View full text Add to dashboard Cite

The Bonebridge (®) (BB, Med-El) is a newly designed transcutaneous active bone conductive implant with functional outcome similar to percutaneous bone-anchored hearing systems (BAHS). It is currently approved only for patients ≥18 years. Since the BB allows the skin to remain intact and therefore should be able to overcome some of the issues related to percutaneous BAHS including skin reactions, wound infection and implant extrusion, it would be especially attractive for use in children. We present a preliminary series of the first three cases of BB implantation in children/adolescents (10-16 years). Two subjects were affected by conductive hearing loss (CHL) and one subject by single-sided deafness (SSD). The surgical procedure with transmastoid approach was completed in all cases without complications. Both subjects with CHL showed an increase in speech perception thresholds in quiet from preoperative unaided to 6 months postoperatively with BB of 37 dB, respectively, of 12 dB. The adolescent with SSD attained -3.1 dB unaided vs. -5.6 dB with the BB in the "speech and noise from the front" presentation and +0.5 unaided vs. -5.0 dB with the BB in the "speech from the unilateral deaf side/noise from the normal hearing side" presentation using the adaptive Oldenburg Sentence Test. The results show a straightforward surgical procedure and satisfactory functional gain after BB implantation also in children/adolescents. BB implantation in patients ≤18 years is currently an "off-label use" so that detailed information about alternative treatment options, operation risks and the lack of approval for use in children is essential.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

The bonebridge as a transcutaneous bone conduction hearing system: preliminary surgical and audiological results in children and adolescents

Hassepaß

Bulla

Aschendorff

et al. 2014

Eur Arch Otorhinolaryngol

View full text Add to dashboard Cite

show abstract

“…The scalp wound can be closed in layers, after which the skin flap should be sutured. Osseointegration of the screws is not needed [10]. …”

Section: Introductionmentioning

confidence: 99%

Active Bone Conduction System: Outcomes with the Bonebridge Transcutaneous Device

Bianchin

Bonali

Russo

et al. 2015

ORL

View full text Add to dashboard Cite

Objective: To describe our experience with positioning the Bonebridge (BB) device, a semi-implantable transcutaneous bone conduction implant for patients with conductive and mixed hearing loss as well as for those suffering from single-sided deafness. Methods: The following is a retrospective case review of 4 adults suffering from conductive or mixed hearing loss and single-sided deafness. The BB device was implanted unilaterally via 2 different approaches selected case by case: the presigmoid transmastoid and the retrosigmoid approach. An audiological evaluation in the free field was conducted to observe the functional benefit with this device. The Glasgow Health Status Inventory (GHSI) and the Glasgow Benefit Inventory (GBI) questionnaires were filled out to evaluate patients' quality of life in relationship to the intervention. Results: No intra- or postoperative complications were observed. The performance in the speech test in all 4 cases reached 100% in the aided condition at 65 dB, while in the unaided condition at 65 dB, it was less than 10%. The GHSI and GBI questionnaires showed an improvement in quality of life after implantation. Conclusions: The BB device is a safe and effective solution for individuals with pathologies such as chronic otitis media, atresia auris and otosclerosis with inadequate benefit from conventional surgery or bone conduction hearing aids.

show abstract

“…BAHAs have an inherently high rate of SSI post-operatively and perhaps should be excluded from this analysis [18,19]. Although in our study neither of the two BAHA cases developed an SSI.…”

Section: Discussionmentioning

confidence: 61%